Prodia Diagnostic Line is trading 3.64% down at IDR 212.00 today after weak first-half 2026 results were released on July 30, 2026. - First-half net revenue fell 51.89% year over year to Rp13.70 billion. - The company swung to an Rp8.84 billion net loss from prior-year profit. - Clinical-chemistry product sales dropped 73.73%, while operating costs increased.